2025³â 06¿ù 16ÀÏ ¿ù¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

GRAMINEX, L.L.C. Final Publication of a Peer Reviewed Clinical Trial with Graminex Flower Pollen Extract Focusing on Women¡¯s Urinary Incontinence in

´º½ºÀÏÀÚ: 2024-05-19

DESHLER, OHIO -- Graminex, L.L.C. is pleased to announce publication of a peer reviewed clinical study with Graminex Flower Pollen Extract for women’s urinary incontinence and urinary health in Current Urology. The study was conducted as a randomized, double-blind, placebo-controlled study to investigate the effectiveness of Graminex Flower Pollen Extracts in 114 healthy women with urinary incontinence. It was concluded that significant and meaningful reductions in UI severity were found in the Graminex RCT Fem™ UI study group along with significant improvement in stress-induced urinary leakage volume with the PollenBerry study group. A full version is available at: Current Urology - Original Article

“Many women experience urinary incontinence throughout their lives during postpartum, menopause, and the natural aging process. There is limited natural support to help improve the symptoms of urinary incontinence currently on the market. With this peer reviewed publication, Graminex is excited to offer a natural product to help improve women’s lives, when it’s needed most,” said Colleen May, CBO.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Lenovo and Bellevue University Team Up to Offer Supply Chain and Logistics Education to Deliver ¡°Smarter Technology for All¡±
Byondis Doses First Patient in Phase 1 Trial of Novel SIRP¥á-Directed Antibody BYON4228 for Advanced or Metastatic Solid Tumors
GCT Semiconductor and Iridium Sign MOU to Collaborate on Integrating Iridium NTN Direct℠ Service into GCT Chipset
Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus¡¯ Biologics Manufacturing in the US
Biocytogen Secures Japan Patent for RenMab Platform, Expands Global Patent Portfolio for RenMice Fully Human Antibody/TCR Platform
Takeda and Nature Announce Call for Applications Now Open for 2026 Innovators in Science Award
Protagonist & Takeda Reveal ASCO Plenary Results From VERIFY Phase 3 Study Of Rusfertide, Showing Reduced Phlebotomy & Improved Hematocrit Control in

 

Seventh and Eighth O3b mPOWER Satellites to Start Delivering Connectiv...
Textron Aviation European Distribution Center Celebrates 10 Years as I...
Kinaxis Brings AI-Powered Supply Chain Breakthroughs to Tokyo at Kinex...
OpenGMSL¢â Association Announces Formation to Revolutionize the Future...
GCT Semiconductor Celebrates Major Milestone with Delivery of 5G Chips...
FDA Grants Priority Review for Zoliflodacin NDA to Treat Uncomplicated...
Rubedo¡¯s ALEMBIC¢â identifies senescent ¡°zombie¡± neurons linked to ...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..